| Abstract | In order to evaluate the efficacy of cefoxitin, 25 patients with serious pelvic infections admitted to a community hospital were treated with the drug. Twenty-one patients (84%) responded to this therapy. Three of the four failures (75%) had a pelvic abscess. Resistant organisms included Staphylococcus aureus, Pseudomonas aeruginosa and enterococci. The adverse reactions encountered were due to localized phlebitis, which occurred in three patients (12%). The study demonstrated that cefoxitin was successful as a single agent in the treatment of serious soft-tissue pelvic infections. |
| Authors | W D Hager, P S McDaniel
(Affiliation: Department of Obstetrics and Gynecology, Central Baptist Hospital, Lexington, Kentucky.)
|
| Journal | The Journal of reproductive medicine
(J Reprod Med)
Vol. 28
Issue 5
Pg. 337-40
(May 1983)
ISSN: 0024-7758 UNITED STATES |
| PMID | 6152988
(Publication Type: Journal Article)
|
| Chemical References |
|
| Topics |
- Adult
- Bacterial Infections
(diagnosis, drug therapy, microbiology)
- Cefoxitin
(therapeutic use)
- Drug Evaluation
- Drug Resistance, Microbial
- Female
- Humans
- Infusions, Intravenous
- Length of Stay
(statistics & numerical data)
- Microbial Sensitivity Tests
- Middle Aged
- Pelvic Inflammatory Disease
(diagnosis, drug therapy, microbiology)
- Thrombophlebitis
(chemically induced)
- Treatment Failure
|
